Clinical Trials Directory

Trials / Unknown

UnknownNCT01074567

DMSO Efficacy in IC/PBS Patients During and After Treatment

Efficacy of DMSO Cocktail Treatment in Interstitial Cystitis Patients During and After Treatment

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Assaf-Harofeh Medical Center · Other Government
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the efficacy of dimethylsulphoxide (DMSO) cocktail in patients with interstitial cystitis during the treatment period (12 weeks) and after it (at 6 weeks, 3, 6 and 12 month).

Detailed description

The modern treatment of IC is a multi-modal treatment which includes behavioural treatment, physiotherapy of the pelvic floor musculature, oral medication (e.g. Amitryptiline) and intra-vesical instillation (e.g. DMSO, steroids, heparin). These treatments were found to be effective in a number of studies and are approved by the FDA. However, the optimal duration of intra-vesical instilation is not known. All patients with IC (according to the international continence society criteria) will receive 12 weekly intra-vesical instillation of DMSO. All patients will fill an O'leary-Sant questionaire and a urination diary before treatment, after 3, 6, 9 and 12 treatments and at 6 weeks, 3, 6 and 12 month after the end to the treatment.

Conditions

Interventions

TypeNameDescription
DRUGDMSO cocktailintra-vesical: DMSO 50% in 50 cc water for injection 10 cc heparin 5000 IU hydrocortisone 100 mg bupivacaine 0.125%

Timeline

Start date
2009-12-01
Primary completion
2011-12-01
Completion
2012-12-01
First posted
2010-02-24
Last updated
2011-04-05

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01074567. Inclusion in this directory is not an endorsement.